WCCT Global, an Altasciences company, is a full-service early phase contract research organization (CRO) for the pharmaceutical, biotechnology and medical device industries. We are specialized regulatory and clinical development professionals who offer an innovative, agile and collaborative approach to every program we deliver.
Our Mission: To offer our clients a simple, integrated, outsourcing solution(s) with a focus on customer service that removes the need for multiple service providers during the early stages of drug development. Whether for one study or an entire program, we are committed to helping our clients reach critical decision making milestones sooner by improving ‘speed and ease’ from lead candidate selection to clinical proof of concept with the goal of getting better drugs to the people who need them, faster. As a partner, we continuously look for ways to build our relationships through communication and range of capabilities, offering scientific guidance and creating an environment that provides value for our clients, respect for our participants, care for our research animals, as well as growth for our employees.
WCCT Global, an Altasciences company, offers U.S. and international sponsors access to an expanded breadth of clinical research offerings. Our emphasis is on overseeing and executing early phase trials in healthy volunteers and special populations. We have extensive experience with Phase 1 clinical trials, including First-in-Human (FIH), SAD/MAD, PK/PD, BA/BE, and devices. Our focus includes Ethnobridging, First-in-Human, Infectious Disease & Vaccines, Ophthalmology and Women’s Health. We are an industry-leader in conducting Asian Ethnic Bridging studies (specifically in Japanese volunteers), at our Phase 1 Unit in Cypress, CA.